课题基金 / 基金详情

What if HIV were unable to develop resistance against a new therapeutic agent?

What if HIV were unable to develop resistance against a new therapeutic agent?
如果艾滋病毒无法对新治疗药物产生耐药性怎么办？
批准号：
310139
负责人：
Wainberg Mark A
金额：
$22.37万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2017-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=310139&lang=en
关键词：
Allele-Specific Pcr Hiv Drug Resistance Hiv Transmissibility K65r Mutation Viral Replicative Fitness Viral Transmission Clusters

项目摘要

项目成果

Wainberg Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A Cure for HIV? We have discovered that the occurrence of drug resistance against one of the newest anti-HIV compounds now being studied may prevent the ability of HIV to replicate. Moreover, we are hopeful that such replication-deficient viruses may al
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic signatures and functional phenotypes implicated in HIV-1 transmission and drug resistance
The Botswana-Canada AIDS Vaccine Discovery Partnership
The Botswana-Canada AIDS Vaccine Discovery Partnership
The Impact of HIV Drug Resistance Mutations in Different Viral Subtypes on Viral Fitness and Phenotype
海外基金